GE HealthCare stock holds firm after BTIG keeps its buy call
Published on 08/20/2026 at 12:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
GE HealthCare Technologies Inc. (ISIN: US36266G1076) is trading after a fresh $79 price target from BTIG Research and a July 29, 2026 earnings release that showed $5.29 billion in revenue and adjusted EPS of $1.13.
Brokerage call and valuation
A recent note reported by MarketBeat said BTIG Research reiterated its buy rating and lifted the target to $79, while the same report put the average price target at $77.73 and the shares at $72.63 at the open.
That leaves the stock below both the single-firm target and the broader average, a gap of $6.37 to BTIG's level and $5.10 to the Street average, based on the figures in that report.
Latest quarter
On July 29, 2026, GE HealthCare reported quarterly revenue of $5.29 billion and adjusted EPS of $1.13, compared with $5.26 billion expected for sales and $1.04 expected for earnings in the same report.
The quarter also showed 5.8 percent year-over-year revenue growth, with EPS up from $1.06 in the prior-year quarter, a concrete comparison that keeps the latest operating trend in view.
Ultrasound systems
The company's portfolio includes compact ultrasound systems, a product area that has recently been highlighted in market coverage as part of its AI-enabled imaging push.
Shares and market data
At the most recent intraday snapshot, GEHC traded at $75.13, up 3.44 percent, with market cap listed at $33.935 billion and an intraday beta of 0.82.
The stock opened at $72.63 in the cited brokerage note and has moved above that level during the session, while the same market page showed a market cap of $32.69 billion on August 17, 2026.
Company snapshot
Company: GE HealthCare Technologies Inc.
ISIN: US36266G1076
Ticker: GEHC
Exchange: Nasdaq
Sector / Industry: Health Care / Health Care Equipment
Price (as of August 20, 2026, 10:53 a.m. ET): $75.13 USD
Market cap: $33.935 billion
Index membership: S&P 500
